rs10226360

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.1777+23306A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.465 in 152,024 control chromosomes in the GnomAD database, including 17,480 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.46 ( 17480 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.50

Publications

4 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.634 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.1777+23306A>C intron_variant Intron 11 of 23 ENST00000361727.8 NP_054860.1 Q9UHC6-1A0A090N7T7B2RCH4
CNTNAP2XM_017011950.3 linkc.1777+23306A>C intron_variant Intron 11 of 13 XP_016867439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.1777+23306A>C intron_variant Intron 11 of 23 1 NM_014141.6 ENSP00000354778.3 Q9UHC6-1
CNTNAP2ENST00000636870.1 linkn.1639+23306A>C intron_variant Intron 9 of 21 5
CNTNAP2ENST00000637825.1 linkn.1260+23306A>C intron_variant Intron 8 of 13 5
CNTNAP2ENST00000638117.1 linkn.1680+23306A>C intron_variant Intron 10 of 12 5

Frequencies

GnomAD3 genomes
AF:
0.465
AC:
70607
AN:
151906
Hom.:
17489
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.294
Gnomad AMI
AF:
0.680
Gnomad AMR
AF:
0.450
Gnomad ASJ
AF:
0.430
Gnomad EAS
AF:
0.581
Gnomad SAS
AF:
0.653
Gnomad FIN
AF:
0.516
Gnomad MID
AF:
0.503
Gnomad NFE
AF:
0.541
Gnomad OTH
AF:
0.470
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.465
AC:
70616
AN:
152024
Hom.:
17480
Cov.:
32
AF XY:
0.467
AC XY:
34721
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.294
AC:
12183
AN:
41496
American (AMR)
AF:
0.450
AC:
6871
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.430
AC:
1492
AN:
3472
East Asian (EAS)
AF:
0.580
AC:
3000
AN:
5168
South Asian (SAS)
AF:
0.653
AC:
3146
AN:
4816
European-Finnish (FIN)
AF:
0.516
AC:
5432
AN:
10536
Middle Eastern (MID)
AF:
0.500
AC:
147
AN:
294
European-Non Finnish (NFE)
AF:
0.541
AC:
36738
AN:
67950
Other (OTH)
AF:
0.467
AC:
987
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1895
3790
5684
7579
9474
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
656
1312
1968
2624
3280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.506
Hom.:
34412
Bravo
AF:
0.449
Asia WGS
AF:
0.588
AC:
2044
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
4.7
DANN
Benign
0.68
PhyloP100
1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10226360; hg19: chr7-147206439; API